ParaMedir awarded with more than €1.8 Million in European Funding by Just Transition Fund (JTF)
Groningen, 14th June, 2024 – ParaMedir proudly announces the award of approximately €1.8 million in European funding from the Just Transition Fund (JTF). This funding supports a consortium led by ParaMedir which includes Pieter Oomen Beheer, Health Hub Roden, GitGud Software Development, University Medical Center Groningen (UMCG), Zorggroep Tangenborgh, and Hanze University Groningen in advancing healthcare through innovative biomonitoring solutions by tackling the challenges of diagnosing and monitoring acute and chronic illnesses. Our goal is to enhance biomonitoring for patients with acute and chronic illnesses, such as diabetes, adhering to the "better in, better out" principle.
Expanding on ParaMedir's UriMoni™ device, which uses microbiosensors and microfluidics to monitor key urine biomarkers, this project aims to extend this technology to various biological fluids like urine, sweat, and saliva. Collaborative efforts will result in significant advances not only in ParaMedir’s core technologies but also in adjacent technologies like bioelectronics, and artificial intelligence, with key objectives focused on developing advanced biosensors, microfluidic solutions, and software algorithms for seamless data analysis by creating prototypes for both hospital and home use, along with a cloud-based application for real-time clinical data access integrated with existing health record systems. These advancements will offer real-time health insights, personalized interventions, and reduced hospitalization times.
Source: ParaMedir
